Seeing Is Believing

Currently out of the existing stock ratings of Soumit Roy, 35 are a BUY (74.47%), 12 are a HOLD (25.53%).
Analyst Soumit Roy, currently employed at JONESTRADING, carries an average stock price target met ratio of 28.79% that have a potential upside of 47.55% achieved within 82 days.
Soumit Roy’s has documented 84 price targets and ratings displayed on 22 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on ONCY, Oncolytics Biotech at 16-May-2025.
Analyst best performing recommendations are on CGEM (CULLINAN ONCOLOGY LLC).
The best stock recommendation documented was for CGEM (CULLINAN ONCOLOGY LLC) at 4/17/2024. The price target of $26 was fulfilled within 12 days with a profit of $8.12 (45.41%) receiving and performance score of 37.84.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 10-May-2024
$23
$-2.59 (-10.12%)
$23
1 years 8 months 21 days ago
(10-May-2024)
6/9 (66.67%)
$-2.36 (-9.31%)
90
Sell Since 04-Jan-2023
$26
$0.41 (1.60%)
$9
1 years 9 months 1 days ago
(30-Apr-2024)
3/10 (30%)
$0.73 (2.89%)
235
Hold Since 04-Jan-2023
$22
1 years 9 months 1 days ago
(30-Apr-2024)
2/3 (66.67%)
$2.24 (11.34%)
67
Hold Since 29-Apr-2024
$23
1 years 9 months 2 days ago
(29-Apr-2024)
4/6 (66.67%)
$8.58 (59.50%)
352
Hold Since 29-Apr-2024
$16
$-9.59 (-37.48%)
1 years 9 months 2 days ago
(29-Apr-2024)
0/3 (0%)
$-9.28 (-36.71%)
What Year was the first public recommendation made by Soumit Roy?